Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-wzw2p Total loading time: 0 Render date: 2024-06-06T16:15:43.657Z Has data issue: false hasContentIssue false

4 - Medical Academia and the Pharmaceutical Industry

Published online by Cambridge University Press:  03 March 2010

Shaili Jain
Affiliation:
Aurora Medical Group, Milwaukee, Wisconsin
Get access

Summary

Bob was feeling happy. He had just received the prescriber profiling information that he had requested. It appeared sales of Vivre had gone up after the dinner talk last week. Bob had expected this. The speaker, Dr. Johnson, an eminent academic psychiatrist, was employed by MedCorp to give talks on Vivre. He was a charismatic, much respected clinician with an impeccable CV. He had been involved in the company-sponsored trials for Vivre and had been impressed by the medication. Subsequently, he had become involved in doing many industry-sponsored educational activities for the medication. Dr. Johnson was paid for his time and received tens of thousands of dollars a year in additional income from these activities. Having seen the encouraging figures, Bob called Dr. Johnson to arrange several more speaking engagements over the coming months.

U.S. academic centers have partnered with industry so that academic innovation can be rapidly and efficiently brought to market. Concerns have been raised that academia is no longer as autonomous as it once was and that industry sponsorship may influence the outcome of research and undermine traditionally held academic values.

Examples of academic institutions' relationships with private industry include ownership of stock in the sponsors of research being conducted at the institution and specific research centers and teaching programs in which students and faculty members essentially carry out industry research.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Johns, M M, Barnes, M, Florencio, P S. Restoring balance to industry–academia relationships in an era of institutional financial conflicts of interest: Promoting research while maintaining trust. JAMA 2003; 289(6):741–6CrossRefGoogle Scholar
Brodkey, A C. The role of the pharmaceutical industry in teaching psychopharmacology: A growing problem. Acad Psychiatry 2005; 29(2):222–9CrossRefGoogle ScholarPubMed
Boyd, E A, Bero, L A. Assessing faculty financial relationships with industry: A case study. JAMA 2000; 284(17):2209–14CrossRefGoogle ScholarPubMed
Angell, M. Is academic medicine for sale? N Engl J Med 2000; 342(20):1516–18CrossRefGoogle ScholarPubMed
Brennan, T A, Rothman, D J, Blank, L, Blumenthal, D, Chimonas, S C, Cohen, J J, Goldman, J, Kassirer, J P, Kimball, H, Naughton, J, Smelser, A. Health industry practices that create conflicts of interest. JAMA 2006; 295(4):429–33CrossRefGoogle ScholarPubMed
Davidoff, F. Between the lines: Navigating the uncharted territory of industry-sponsored research. Health Aff (Millwood) 2002; 21(2):235–42CrossRefGoogle ScholarPubMed
Davidoff, F, DeAngelis, C D, Drazen, J M, Hoey, J, Hojgaard, L, Horton, R. Sponsorship, authorship, and accountability. Lancet 2001; 358:854–6CrossRefGoogle ScholarPubMed
Wright, I C. Conflict of interest and the British Journal of Psychiatry. Br J Psychiatry 2002; 180:82–3CrossRefGoogle ScholarPubMed
Just how tainted has medicine become? [Editorial]. Lancet 2002; 359:1167–8CrossRef
Lagnado, M. Increasing the trust in scientific authorship. Br J Psychiatry 2003; 183:3–4CrossRefGoogle ScholarPubMed
Bodenheimer, T. Uneasy alliance – clinical investigators and the pharmaceutical industry. N Engl J Med 2000; 342(20):1539–44CrossRefGoogle ScholarPubMed
Rae-Grant, Ø. Challenges of the pharmaceutical–physician boundary. Can J Psychiatry 2003; 48(5):287–8CrossRefGoogle ScholarPubMed
Healy, D, Cattell, D. Interface between authorship: Industry and science in the domain of therapeutics. Br J Psychiatry 2003; 183:22–7CrossRefGoogle ScholarPubMed
Krimsky, S, Rothenberg, L S, Stott, P, Kyle, G. Scientific journals and their authors' financial interests. Psychother Psychosom 1998; 67(4–5):194–201CrossRefGoogle ScholarPubMed
Choudhry, N K, Stelfox, H T, Detsky, A S. Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA 2002; 287(5):612–17CrossRefGoogle ScholarPubMed
Smith, R. Medical journals and pharmaceutical companies: Uneasy bedfellows. BMJ 2003: 326(7400):1202–5CrossRefGoogle ScholarPubMed
Ashar, B H, Miller, R G, Getz, K J, Powe, N R. Prevalence and determinants of physician participation in conducting pharmaceutical-sponsored clinical trials and lectures. J Gen Intern Med 2004; 19(11):1140–5CrossRefGoogle ScholarPubMed
Warner, T D, Roberts, L W. Scientific integrity; fidelity and conflicts of interest in research. Curr Opin Psychiatry 2004; 17:381–5CrossRefGoogle ScholarPubMed
Mirowski, P, Horn, R. The contract research organization and the commercialization of scientific research. Soc Stud Sci 2005; 35(4):503–48CrossRefGoogle ScholarPubMed
Puttagunta, P S, Caulfield, T A, Griener, G. Conflict of interest in clinical research. Health Law Rev 2002; 10(2):30–2Google ScholarPubMed
Safer, D J. Design and reporting modifications in industry-sponsored comparative psychopharmacology trials. J Nerv Ment Dis 2002; 190(9):583–92CrossRefGoogle ScholarPubMed
Baker, C B, Johnsrud, M T, Crismon, M L, Rosenheck, R A, Woods, S W. Quantitative analysis of sponsorship bias in economic studies of antidepressants. Br J Psychiatry 2003; 183:498–506CrossRefGoogle ScholarPubMed
Melander, H, Ahlquist-Rastad, J, Meijer, G, Beerman, B. Evidence b(i)ased medicine. BMJ 2003: 326(7400):1171–3CrossRefGoogle ScholarPubMed
Lexchin, J, Bero, L A, Djulbegovic, B, Clark, O. Pharmaceutical industry sponsorship and research outcome and quality: Systematic review. BMJ 2003; 326(7400):1167–70CrossRefGoogle ScholarPubMed
Rennie, D. Fair conduct and fair reporting of clinical trials. JAMA 1999; 282(18):1766–8CrossRefGoogle ScholarPubMed
Dickersin, K, Rennie, D. Registering clinical trials. JAMA 2003; 290(4):516–23CrossRefGoogle ScholarPubMed
Steinbrook, R. Registration of clinical trials – voluntary or mandatory? N Engl J Med 2004; 351(18):1820–2CrossRefGoogle ScholarPubMed
Rennie, D. Trial registration: A great idea switches from ignored to irresistible. JAMA 2004; 292(11):1359–62CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×